Service applies CLSI M100 guidelines to PCR results, delivering clear insights on pathogens and resistance markers to support physicians and labs BIRMINGHAM, Ala., Sept. 18, 2025 /PRNewswire/ -- ...
A recent McKnight’s article on a new consensus statement recommending against PCR urine testing in long-term care raises valid concerns about inappropriate use, particularly when results are ...
PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection with higher throughput for efficient and accurate diagnosis. Neeraj Jadhav, Industry Analyst at ...
The MarketWatch News Department was not involved in the creation of this content. Service applies CLSI M100 guidelines to PCR results, delivering clear insights on pathogens and resistance markers to ...
Frost & Sullivan recently assessed the multiplexed urinary tract infection detection industry and, based on its findings, recognizes PathogenDx with the 2024 North American New Product Innovation ...
- The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026 - Selected researchers will ...
An expert panel convened by the nation’s top post-acute care medical organization has recommended against the routine use of urine PCR tests to diagnose urinary tract infections. Such tests have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback